First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline

Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international consensus on a preferred first line treatment approach. In the recently revised Dutch guideline for WM,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-10-01
Saila:	Hemato
Gaiak:	Waldenstrom’s Macroglobulinemia guideline ibrutinib zanubrutinib DRC bendamustine
Sarrera elektronikoa:	https://www.mdpi.com/2673-6357/3/4/47
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!